Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, February 25, 2026

Angiotensin II-Stimulating vs Inhibiting BP Drugs: Stimulating Class Linked to Lower Dementia Pathology Risk, JAMA

 Have your competent? doctor figure out if you are on the right class of blood pressure drugs.

Here's info to bring to your doctor:
Angiotensin II–stimulating antihypertensives are a class of blood pressure medications that, while lowering systemic blood pressure, are thought to increase the stimulation of protective
and
receptors, potentially offering cognitive benefits. These include Angiotensin II Receptor Blockers (ARBs) (e.g., losartan), dihydropyridine Calcium Channel Blockers (CCBs) (e.g., amlodipine), and thiazide diuretics.

Common Angiotensin II Antagonist Drugs (Sartans)
The following are major ARBs approved for clinical use, often identified by the suffix "-sartan": 
  • Azilsartan (Edarbi): Used for hypertension.
  • Candesartan (Atacand): Used for hypertension and heart failure.
  • Eprosartan
    (Teveten):
    Used for hypertension
    .
  • Irbesartan (Avapro): Used for hypertension and diabetic nephropathy.
  • Losartan (Cozaar): Commonly used for hypertension and stroke reduction.
  • Olmesartan (Benicar): Used for hypertension.
  • Telmisartan (Micardis): Used for hypertension and cardiovascular risk reduction.
  • Valsartan (Diovan): Used for hypertension and heart failure. 
Mechanism of Action and Clinical

Angiotensin II-Stimulating vs Inhibiting BP Drugs: Stimulating Class Linked to Lower Dementia Pathology Risk, JAMA

No comments:

Post a Comment